Exane Derivatives’s Oxford Lane Capital OXLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Hold
0
-$10 702
2019
Q1
Sell
-579
Closed -$29.2K 625
2018
Q4
$28.1K Hold
579
0.01% 420
2018
Q3
$30.6K Sell
579
-598
-51% -$32.7K 0.01% 396
2018
Q2
$61.3K Buy
1,177
+89
+8% +$4.76K 0.01% 374
2018
Q1
$55.1K Sell
1,088
-318
-23% -$16.1K 0.01% 345
2017
Q4
$70.6K Sell
1,406
-543
-28% -$28K 0.01% 317
2017
Q3
$99.4K Sell
1,949
-502
-20% -$26.4K 0.02% 260
2017
Q2
$121K Sell
2,451
-25
-1% -$1.34K 0.03% 254
2017
Q1
$138K Buy
+2,476
New +$137K 0.03% 210

Other funds holding OXLC

Exane Derivatives's OXLC Position: Q2 2019 in Review

Exane Derivatives held its Oxford Lane Capital (OXLC) position steady in Q2 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #702.

Exane Derivatives first reported a position in OXLC in Q1 2017 and has held it in 8 quarters since. The position peaked at $138K in Q1 2017. 39 funds tracked by Wall St. Rank hold OXLC as of Q2 2019.

  • Exane Derivatives held 0 shares of Oxford Lane Capital worth $0 as of Q2 2019.
  • Exane Derivatives left its Oxford Lane Capital share count unchanged in Q2 2019.
  • Oxford Lane Capital made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2019, its #702 holding.
  • Exane Derivatives first reported a position in Oxford Lane Capital in Q1 2017 and has held it in 8 quarters since.
  • Exane Derivatives's Oxford Lane Capital position peaked at $138K in Q1 2017.
  • 39 funds tracked by Wall St. Rank held Oxford Lane Capital as of Q2 2019.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.